Health Professional Radio - Podcast
Squarex - New Investigational Drug for HSV
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:10:16
- Mas informaciones
Informações:
Sinopsis
New CEO of Squarex, Jack V. Talley discusses the positive results of the phase 2 study on their new investigational drug candidate SQX770, a topical immunomodulator treatment to extend the time between herpes labialis (recurrent cold sores) outbreaks caused by Herpes Simplex Virus 1 or Herpes Simplex Virus 2. Squarex is a clinical-stage pharmaceutical company.
